The Phase 2 and 3 clinical trials for Coronavirus vaccine (covaxin) for age 2 to 18 years have been completed…
Union minister Mansukh Mandaviya announced yesterday that the government has approved Bharat Biotech's Ankleshwar-based manufacturing plant to produce the COVID-19…
An expert panel of India's central drug authority has recommended that Bharat Biotech be given permission to conduct a study…
Bharat Biotech, the maker of coronavirus disease vaccine Covaxin, is expected to start paediatric trials from June, the company's Business…
Few side effects of vaccination are common and that shouldn’t deter anyone from taking it said Dr. Raches Ella, Head-Business…
Bharat Biotech on Thursday said it has ramped up additional manufacturing capacities for the Covaxin covid-19 jabs as the country…
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…
In a recent announcement made by Bharat Biotech, the price of its Covid-19 vaccine, Covaxin has been reduced from Rs.…
COVAXIN shows 78% clinical and 100% efficacy against severe COVID-19 The COVAXIN developed and manufactured by Bharat Biotech, “neutralizes multiple…
India’s government has granted Rs. 45.67 billion to Serum Institute of India (SII) and Bharat Biotech to boost production of…